Download New OCT Devices Incorporate Heidelberg Engineering`s

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Channel coordination wikipedia , lookup

Transcript
FOR IMMEDIATE RELEASE
US Contact: Allison Potter
Mobile: +1 814.221.2661
E-mail: [email protected]
Germany Contact: Christina Wahl
Tel: +49 6221.6463.0
Email: [email protected]
New OCT Devices Incorporate Heidelberg Engineering’s
BluePeak™ Technology
Drug Studies Using Blue Laser Autofluorescence to Track Dry AMD
Vista, California and Heidelberg, Germany- September 11th, 2009 – Heidelberg
Engineering today announced two new additions to the SPECTRALIS® family of multimodality ophthalmic imaging devices. The new models add BluePeak laser autofluorescence
to the company’s more economical spectral-domain OCT (SD-OCT) devices.
“BluePeak autofluorescence adds a functional indicator of retinal health by measuring the
metabolic activity of the RPE,” said Karl Csaky MD, PhD, Retina Foundation of the
Southwest. “Recent results from the Geographic Atrophy Progression (GAP) study clearly
demonstrate the need to use autofluorescence to track the progression of geographic atrophy
for dry AMD patients. This has attracted the interest of the pharmaceutical companies; at
least ten new therapies for dry AMD are now under clinical investigation. The combination
of BluePeak and OCT will enable clinicians to potentially take advantage of these emerging
therapeutics in the same way that ranibizumab and OCT changed the management of wet
AMD.”
BluePeak laser autofluorescence is now available on five of the SPECTRALIS models.
“The SPECTRALIS imaging platform was designed to be modular,” said Carole McCallum,
marketing manager for Heidelberg Engineering. “These new models demonstrate our ability
to incorporate new imaging technology into our existing platform and offer clinicians more
utility and value with the multi-modality design.”
There are now seven different SPECTRALIS models available. The main differences
between the models are which of the available imaging modalities they include, whether the
instrument is set up for Wide Field imaging, and hardware upgrade options. Product line
details are available at www.HeidelbergEngineering.com.
About Heidelberg Engineering GmbH
Headquartered in Heidelberg, Germany, this privately-held company is a leader in lightbased medical devices for ophthalmic applications. The company designs, manufactures and
markets a variety of instruments that aid in the diagnosis and management of anterior and
posterior disease of the eye. The U.S. corporate office is located in Vista, California.
###